EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients

Frederik Haupenthal iD, Konstantin Doberer, Sebastian Kapps iD, Johannes Kläger, Florian Bauernfeind, Kris Denhaerynck iD, Alexander Kainz, Sabina De Geest iD, Gregor Bond iD

Nephrology Dialysis Transplantation · 30.10.2025 · 40 (11) · 2081-2090

DOI: 10.1093/ndt/gfaf078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, online erschienen am 28.04.2025. Verfasst von Frederik Haupenthal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Kidney Transplantation, Immunosuppressive Agents, Graft Rejection, Self Report. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Austrian Science Fund, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

After kidney transplantation adherence to immunosuppressive medication is crucial for graft survival and its assessment requires valid measurements. The Basel Assessment of Adherence-to Immunosuppressive Medications Scale (BAASIS) is a validated self-report tool to detect non-adherence, however, its ability to predict clinically relevant outcomes remains to be established.

Methods

In this prospective cohort study including 226 consecutive kidney graft recipients transplanted at the Medical University of Vienna between 2018 and 2019 the adherence toward immunosuppressive medication was monitored for 2 years after transplantation. The BAASIS was applied at the first outpatient visit and at months 3, 6, 9, 12, and 24 post-transplant to assess the implementation and persistence phase of adherence. Non-adherence was defined by any positive response to one of the BAASIS-items. The primary endpoint was biopsy-proven allograft rejection defined by the Banff meeting report during a maximum follow-up of 4 years.

Results

Of the total study cohort [median age 56 years (IQR 46–63), 75 (33%) female], 125 recipients (55%) reported non-adherence at least once. Self-reported non-adherence increased within the first 3 months from 11% to 31% and remained between 27% and 32% at months 6 to 24 post-transplant. Non-adherent recipients experienced more allograft rejections than adherent patients (24%, n = 30 vs. 7%, n = 7; P < .001) during a median follow-up of 3.7 years (IQR 1.0–4.0). Using a time-dependent Cox regression model, the adjusted hazard ratio for allograft rejection associated with previously reported non-adherence was 2.90 (95% confidence interval (CI) 1.51–5.58; P = .001) accounting for recipient sex, age at transplantation, and history of previous transplantation.

Conclusion

Our findings support the clinical value of the BAASIS. Its implementation into routine post-transplant care may facilitate the identification of clinically relevant medication non-adherence, enabling timely interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationImmunosuppressive AgentsGraft RejectionSelf ReportMedication AdherenceKidney Failure, ChronicHumansFemaleMaleMiddle AgedProspective StudiesGraft SurvivalFollow-Up StudiesPrognosis

Stichwörter der Autor:innen

BAASISallograft rejectionimmunosuppressionkidney transplantationmedication adherence

Substanzen

Immunosuppressive Agents

Autor:innen und Institutionen

  • Division of Nephrology and Dialysis, Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Department of Pathology, Medical University of Vienna, Vienna, Austria.
  • Institute of Nursing Science, Department of Public Health, University of Basel, Basel, Switzerland.
  • Academic Centre for Nursing and Midwifery, Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

ORCID-Profile: Frederik Haupenthal, Sebastian Kapps, Kris Denhaerynck, Sabina De Geest, Gregor Bond

Förderung

  • Austrian Science Fund
  • European Union

Zitieren

APA

Haupenthal, F., Doberer, K., Kapps, S., Kläger, J., Bauernfeind, F., Denhaerynck, K., Kainz, A., De Geest, S., & Bond, G. (2025). Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients. Nephrology Dialysis Transplantation, 40(11), 2081-2090. https://doi.org/10.1093/ndt/gfaf078

Vancouver

Haupenthal F, Doberer K, Kapps S, Kläger J, Bauernfeind F, Denhaerynck K, et al. Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients. Nephrology Dialysis Transplantation. 2025;40(11):2081-2090. doi:10.1093/ndt/gfaf078

BibTeX
@article{Haupenthal2025,
  author = {Haupenthal, Frederik and Doberer, Konstantin and Kapps, Sebastian and Kläger, Johannes and Bauernfeind, Florian and Denhaerynck, Kris and Kainz, Alexander and De Geest, Sabina and Bond, Gregor},
  title = {Self-reported non-adherence to immunosuppressive medication detected by the BAASIS predicts allograft rejections in kidney transplant recipients},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  volume = {40},
  number = {11},
  pages = {2081--2090},
  doi = {10.1093/ndt/gfaf078}
}
Kostenlos starten →